Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activitysort descending Investigator Unit Sponsor Date
Epitope Open-Label Extension Study to Evaluate the Long-Term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX) Contract $173,290.72 Clinical Trial Heather Cassell Asthma/Airway Disease Rsch Ctr Pharmaceutical Research Associates 02/2020
FROzEN-AF: Safety and Effectiveness IDE Trial for Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation Contract $122,626.40 Clinical Trial Wilber Su COM Phx Internal Medicine Boston Scientific Corporation 07/2020
Phase 2 Window Study of Two Dose Levels of SAR439859 (SERD) Versus Letrozole in Newly Diagnosed Pre-Operative Post-Menopausal Patients with ER Positive, HER2 Negative Primary Breast Cancer Contract $95,384.00 Clinical Trial Nova Foster Cancer Center Division Sanofi-Aventis United States Incorporated 09/2020
A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies Contract $468,451.00 Clinical Trial Alejandro Recio Boiles Cancer Center Division Atreca, Inc. 10/2020
A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab or Cemiplimab in Patients with Advanced Solid Tumors Contract $157,802.00 Clinical Trial Montaser Shaheen Cancer Center Division Exicure, Inc. 06/2020
FLowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) Contract $125,613.76 Clinical Trial Christopher Goettl COM Phx Radiology Inari Medical 02/2020
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (ICECAP) Cooperative Agreement $383,000.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine University of Michigan 07/2020
SWOG Network Group Operations Center of the NCTN Cooperative Agreement $900,000.00 Clinical Trial Daniel Persky Cancer Center Division Oregon Health and Science University 09/2020
A Master Protocol Assessing the Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-COV-2 Monoclonal Antibodies for the Treatment of Ambulatory Patients with COVID-19 Contract $254,412.60 Clinical Trial Billie Bixby Medicine Regeneron Pharmaceuticals, Inc 10/2020
A Phase II Trial of PET-Directed Therapy using AVD (Doxorubicin, Vinblastine, and Dacarbazine) Plus Brentuximab Vedotin Induction Chemotherapy, with or without Brentuximab Vedotin Plus Nivolumab, Foll Contract $40,100.00 Clinical Trial Abhijeet Kumar Cancer Center Division Mayo Foundation for Medical Education and Research (Mayo Clinic) 06/2020
Phase 1/1b Multicenter, Open-Label, First-in-Human Dose Escalation and Dose Expansion Study to Assess Safety and Tolerability of Orally Administered PMD-026 in Patients with Metastatic Breast Cancer w Contract $100,897.00 Clinical Trial Pavani Chalasani Cancer Center Division Phoenix Molecular Designs (Canada) 02/2020
SEER-Lung: A Prospective Blood Sample Collection Study to Develop and Validate a Panel of Protein-based Biomarkers in Patients with Pulmonary Nodules Contract $23,319.00 Clinical Trial Raed Alalawi COM Phx Internal Medicine Seer, Inc. 07/2020
Web-based Physical Activity Intervention for Children with ALL Grant $175,000.00 Clinical Trial Holly Pariury Cancer Center Division Children's Hospital of Philadelphia 09/2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome (ARDS) Contract $167,627.92 Clinical Trial Christian Bime Medicine Kinevant Sciences, Inc. 10/2020
A Phase III, Multicenter, Open-Label, Extension Clinical Trial to Demonstrate the Effectiveness and Safety of Liposomal Cyclosporine A (L-CsA) Inhalation Solution Delivered via the PARI... Contract $432,030.00 Clinical Trial Ramachandra Sista COM Phx Internal Medicine Covance, Incorporated 06/2020
SWOG NCORP Research Base Cooperative Agreement $54,000.00 Clinical Trial Daniel Persky Cancer Center Division Oregon Health and Science University 07/2020
A Phase 2 Open-Label Study of Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-cell Lymphoma (PTCL) in Adults Age 60 and Above Contract $147,691.00 Clinical Trial Daniel Persky Cancer Center Division Seattle Genetics, Incorporated 05/2020
A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Anti-Tumor Activity of ABBV-321 in Subjects with Advanced Solid Tumors Associated with Overexpression of the Epidermal Growth Factor Recept Contract $854,975.00 Clinical Trial Hani Babiker Cancer Center Division AbbVie Incorporated 10/2020
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with Either Durvalumab Monotherapy or Durvalumab Plus Bevacizumab Contract $208,612.70 Clinical Trial Gregory Woodhead Cancer Center Division Astrazeneca 06/2020
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants with Previously Treated Locally Advanced/Metastatic or Surgically Unresectable.. Contract $171,440.00 Clinical Trial Aaron Scott Cancer Center Division Incyte Corporation 05/2020
A Phase 2 Randomized Study of Adjuvant Immunotherapy with the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma Contract $206,150.52 Clinical Trial Montaser Shaheen Cancer Center Division PPD Investigator Services, LLC. 10/2020
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients with COVID-19 Pneumonia Contract $3,236,387.50 Clinical Trial Sachin Chaudhary Medicine Syneos Health 06/2020
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects Contract $79,672.00 Clinical Trial Ramachandra Sista COM Phx Internal Medicine Vertex Pharmaceuticals, Incorporated 05/2020
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine in Participants Undergoing Surgeries that Include a Bowel Resection or Bowel Transection Contract $586,018.76 Clinical Trial Bellal Joseph Surgery Shionogi Inc 10/2020
A Randomized, Double-blind, Placebo-controlled Clinical Trial of Fluconazole as Early Empiric Treatment of Coccidioidomycosis Pneumonia (Valley Fever) in Adults Presenting with Community Acquired... Contract $593,373.00 Clinical Trial John Galgiani Valley Fever Ctr for Excellnc Duke University 06/2020

Pages